⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | LIC MF Large & Midcap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | LIC MF | HDFC MF |
| Category | Equity - Large & Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹41.93 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY LargeMidcap 250 - TRI | BSE Health Care - TRI |
| Fund Manager | Sudhanshu Asthana | Nikhil Mathur |
| Inception | 25 Feb 2015 | 04 Oct 2023 |
| Returns | ||
| 1Y | -7.92% | 22.64% |
| 3Y | 12.04% | 30.41% |
| 5Y | 9.63% | — |
| Since Inception | 13.10% | 29.15% |
| Risk | ||
| 15.47 | 14.07 | |
| 1.02 | 0.59 | |
| 0.45 | 1.59 | |
| 1.62 | 21.67 | |
| 0.86 | 3.48 | |
| -11.35% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.56% | 1.03% |
| Exit Load | Nil upto 12% on units and 1% on remaining units on or before 3M, Nil after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹200 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
LIC MF94%
HDFC MF94%
5.9%Only 5.9% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingLIC MFHDFC MF
Divi's Laboratories Ltd.3.02%9.39%
Apollo Hospitals Enterprise Ltd.2.91%3.69%
Category context: Equity vs Equity. Open the full Screener →